| |
Regional Differences across Europe in Advanced Fibrosis and Cirrhosis among HIV/HCV Co-infected Persons between 2010-2015....26% of individuals with HIV/HCV had fibrosis ≥F3.... need to prioritise HIV and HCV screening, linkage to care and treatment across Europe
|
| |
| |
Reported by Jules Levin
HepHIV 2017 Conference Malta 31 January - 2 February 2017
S Amele1, L Peters2, JD Lundgren2,3, JK Rockstroh4, H Sambatakou5, T Staub6, F Maltez7, C Leen8, C Pedersen9, JM Gatell
Artigas10, S Moreno11, R Matulionyte12, G Kyselyova13, I Karpov14, D Jilich15, M Parczewski16, K Zilmer17, H Elinav18,
K Lacombe19, M Cavassini20, J Tomazic21 and A Mocroft1 on behalf of the EuroSIDA study group
......"26% of individuals with HIV/HCV had fibrosis ≥F3, with significant differences between regions likely attributable to duration of HCV infection.....The prevalence of fibrosis ≥F3 and the relationship between CD4 and fibrosis ≥F3 highlights the need to prioritise HIV and HCV screening, linkage to care and treatment across Europe."
Reported by Jules Levin
HepHIV 2017 Conference Malta 31 January - 2 February 2017
S Amele1, L Peters2, JD Lundgren2,3, JK Rockstroh4, H Sambatakou5, T Staub6, F Maltez7, C Leen8, C Pedersen9, JM Gatell Artigas10, S Moreno11, R Matulionyte12, G Kyselyova13, I Karpov14, D Jilich15, M Parczewski16, K Zilmer17, H Elinav18, K Lacombe19, M Cavassini20, J Tomazic21 and A Mocroft1 on behalf of the EuroSIDA study group
Sarah Amele
Research Department of Infection
and Population Health
University College London
Tel: +44 20 7794 0500 Ext 34611
sarah.amele.16@ucl.ac.uk
|
|
| |
| |
|
|
|
